Pinealon

Pinealon (Oral)

Pinealon is a short synthetic tripeptide (Glu-Asp-Arg) studied in the peptide bioregulator literature for potential neuroprotective and cognitive effects, especially in aging and stress models. It is commonly discussed as a pineal/brain-directed bioregulator. Evidence quality varies and much is preclinical or regional.

Dosing Protocols

Reconstitute: Add 3.0 mL bacteriostatic water → ~6.67 mg/mL concentration.
Typical daily range: 1.0–2.0 mg once daily for 10–20 day cycles.
Easy measuring: At 6.67 mg/mL, 1 unit = 0.01 mL ≈ 66.7 mcg on a U-100 insulin syringe.
Storage: Lyophilized: freeze at −20 °C; reconstituted: refrigerate at 2–8 °C, avoid freeze-thaw cycles.

Schedule: Daily subcutaneous injections for 10–20 days. Repeat cycles every 2–3 months.
Cycle Length: Standard 10–20 days; repeat cycles every 2–3 months.
Goal: Support neuroprotection, cognitive function, and cellular resilience in brain tissue through peptide bioregulation.

Frequency: Inject once daily subcutaneously, preferably in the morning or early afternoon. Standard cycles are 10–20 days, with the option to extend to 28 days. Repeat cycles can be administered every 2–3 months as needed.

Phase	Dose	Syringe (U-100)
Days 1–5	1.0 mg (1,000 mcg)	15 units (0.15 mL)
Days 6–14	1.5 mg (1,500 mcg)	22.5 units (0.225 mL)
Days 15–20	2.0 mg (2,000 mcg)	30 units (0.30 mL)

Benefits

• Studied for neuroprotection under oxidative and excitotoxic stress (preclinical)
• May support attention, memory, and cognitive performance in aging/stress models (limited human data)
• Potential support for sleep/circadian resilience via pineal-related signaling hypotheses
• May modulate neuroinflammatory pathways (preclinical)
• Investigated for support of stress tolerance and fatigue resistance (limited evidence)
• Explored for potential protection of retinal/visual pathways in stress models (preclinical)
• May support endothelial function in cerebral microcirculation (hypothesized)

Mechanism of Action

Proposed to act as a gene‑expression modulator affecting neuronal survival pathways. Reported mechanisms in the bioregulator literature include antioxidant effects, normalization of apoptosis-related signaling, modulation of cytokine balance, and potential epigenetic/transcriptional regulation. Direct receptor binding is not clearly established; effects may be pleiotropic and context-dependent.

Side Effects

• Headache
• Vivid dreams or sleep changes
• GI upset
• Irritability/anxiety (rare)
• Allergic reactions (rare)

Side Effect Management

• Dose earlier in the day if sleep disturbance occurs
• Hydrate and reduce dose if headache occurs
• Avoid concurrent stimulants initially
• Discontinue if mood changes are significant

Contraindications

• Pregnancy/breastfeeding
• Bipolar disorder or history of mania (precaution with neuroactive compounds)
• Known hypersensitivity
• Children/adolescents (insufficient data)

Research Citations

PubMed/DOI-linked citations for verification. Many studies are preclinical (animal/in-vitro) or early clinical.

1. Khavinson V, Linkova N. Peptides and aging (bioregulator overview). DOI Link
2. Ashmarin IP, Khavinson V. Regulatory peptides: mechanisms of action. (review). DOI Link
3. Khavinson VKh. Peptide regulation of gene expression and aging (review). DOI Link

---